Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
HES Technology Group
002963
5
Chengdu Haoneng Technology
603809
US OptionsDetailed Quotes
CVAC250516C1000
- 1.10
- 0.000.00%
15min DelayClose May 7 16:00 ET
0.00High0.00Low
1.10Open1.10Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover815.47%IV-39.48%PremiumMay 16, 2025Expiry Date2.47Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9470Delta0.0246Gamma1.31Leverage Ratio-0.0273Theta0.0002Rho1.24Eff Leverage0.0006Vega
CureVac Newsroom
UBS Maintains CureVac(CVAC.US) With Buy Rating, Cuts Target Price to $12
CureVac Analyst Ratings
UBS Trims Price Target on CureVac to $12 From $13, Maintains Buy Rating
BofA Securities Initiates CureVac(CVAC.US) With Sell Rating, Announces Target Price $2.5
JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Cuts Target Price to $10
CureVac's Promising Pipeline and Legal Wins Justify Buy Rating
CureVac Analyst Ratings
JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16
Analysts' Top Healthcare Picks: CureVac (CVAC), GE Healthcare Technologies Inc (GEHC)
JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16
JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16
CureVac: Strong Financial Position and Promising Pipeline Justify Buy Rating
CureVac Analyst Ratings
JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16
JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16
CureVac's Promising Cancer Vaccine Candidate CVGBM Elicits Buy Rating
Deutsche Bank Maintains CureVac(CVAC.US) With Hold Rating, Cuts Target Price to $3.9
CureVac (CVAC) Receives a Hold From Deutsche Bank
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)
CureVac Analyst Ratings
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now